After months of waiting, we finally have detailed information on the safety and efficacy of the first Covid-19 vaccines that will be distributed in America.
On Thursday, a committee that advises the Food and Drug Administration voted to recommend the Moderna vaccine for an emergency use authorization for people ages 18 and over. Ahead of the decision, the agency shared the most comprehensive data to date on what we know about the shot. The same process happened last week with the Pfizer/BioNTech vaccine, which is now being rolled out across America following an EUA Friday night.
While both vaccines had already been shown to be highly effective, the new data provides a much more granular picture of their side effects and safety profiles.
The Next Six Months Will Be Vaccine Purgatory Sarah Zhang
Editor’s Note:
The Atlantic is making vital coverage of the coronavirus available to all readers. Find the collection here.
With the FDA’s emergency authorization of the first COVID-19 vaccine imminent, the biggest and most complex vaccination campaign in the nation’s history is gearing into action. Planes are ferrying vaccines around the country, hospitals are readying ultracold freezers, and the very first people outside of clinical trials will soon get shots in their arms. The end of the pandemic is in sight.
But vaccines are not an off switch. It will take several months to vaccinate enough Americans to resume normal life, and this interim could prove long, confusing, and chaotic. The next six months will almost certainly bring delays in vaccine timelines, fights over vaccine priority, and questions about how immune the newly vaccinated are and how they should behave. We’ve spent 2020 adjusti
Experts, Politicians Confident in COVID-19 Vaccines wshu.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wshu.org Daily Mail and Mail on Sunday newspapers.